Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation - Millán, O. (Instituto de Salud Carlos III) ; Rovira, J. (Red de Investigación Renal (REDINREN)) ; Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Espinosa, C. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Budde, K. (Charité - Universitätsmedizin Berlin) ; Sommerer, Claudia (Heidelberg University Hospital (Alemanya)) ; Piñeiro, G.J. (Institut Clínic de Nefrologia i Urologia. Servei de Nefrologia i Trasplantament Renal) ; Diekmann, Fritz (Institut Clínic de Nefrologia i Urologia. Servei de Nefrologia i Trasplantament Renal) ; Brunet, M. (Instituto de Salud Carlos III)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>